Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in people with ...

A YOUNG woman has warned others against taking Mounjaro after being admitted to hospital. Clo Natasha, from the UK, took to ...

By Shreoshree Chakrabarty: For individuals managing diabetes, insulin must be administered into the subcutaneous tissue—the layer of fat located between the skin and muscle. This tissue, also called ...